MediciNova, Inc.
MNOV
$1.51
$0.042.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.67% | -44.67% | -32.71% | -28.91% | -8.20% |
| Total Depreciation and Amortization | -3.26% | -5.91% | -2.78% | 4.43% | 12.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.77% | 145.50% | 99.48% | 35.39% | -36.19% |
| Change in Net Operating Assets | 503.24% | 129.95% | -88.22% | -974.64% | 106.94% |
| Cash from Operations | -5.59% | -17.59% | -30.00% | -43.22% | 15.80% |
| Capital Expenditure | -222.22% | 100.00% | 95.77% | 95.77% | 96.58% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -314.29% | 105.56% | 96.71% | -100.00% | -100.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 163.29% | -263.76% | -136.28% | -76.88% | -143.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.32% | -18.03% | -30.13% | -132.74% | -822.76% |